The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma

NCT04262427 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Cyclophosphamide 50mg
DRUG: Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]

Sponsor

The Christie NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]